| 朝陽科技大學 |
2022-03-08 |
不同教學方法對課堂專注力的影響-以會計系專業課程之實體與遠距教學做比較
|
陳政翎;吳佳儀;劉書晴;陳俊瑋;黃閔鋒 |
| 朝陽科技大學 |
2022-03-08 |
中國臨時限電對台商股價之影響
|
吳芷崴;張凱茹;陳妙禎;童詩淳;蕭芷珊;蘇雨涵 |
| 朝陽科技大學 |
2022-03-08 |
初探影響會計師出具繼續經營有疑慮意見事項
|
蕭秋婷;滿家衣;黃俞萍;吳佳軒 |
| 朝陽科技大學 |
2022-03-08 |
會計師輪調對於關鍵查核事項之影響
|
黃軍瑋;蕭勝安;林楚桓;蔡宜?;謝佳君 |
| 朝陽科技大學 |
2022-03-08 |
會計師職業道德之探討
|
許卉玟;余羽?;陳怡菁;巫怡萱;吳采軒;劉怡妏 |
| 朝陽科技大學 |
2022-03-08 |
房地合一2.0之探討
|
張昱輝;曾家鴻;游智凱;黃加慶;郭旻侑 |
| 朝陽科技大學 |
2022-03-08 |
中小企業利用擴大書面審核結算申報制度逃漏營利事業所得稅之研討
|
劉妤婕;黃柏芸;江怡蒨;張旆嘉;柯羽慧;林稚涵 |
| 朝陽科技大學 |
2022-03-08 |
節能減碳與企業價值
|
周汝璟;江云喬;沈庭穎;賴芊琪;董宸彤 |
| 朝陽科技大學 |
2022-03-08 |
財報不實之詐貸－以潤寅案為例
|
林建亨;林孟頡;王盈媗;張鈺瑄;廖峻逸 |
| 朝陽科技大學 |
2022-03-08 |
投資與會計穩健性、盈餘管理之關係探討
|
林玥羽;邱沛玲;葉倩妤;黃沛?;賴沛晴 |
| 朝陽科技大學 |
2022-03-08 |
振興政策對民眾消費行為影響與探討－以振興五倍券為例
|
高沛琪;吳承洧;林珊亦;游啟賢 |
| 朝陽科技大學 |
2022-03-08 |
人工智能與管理會計：神經網路模型之應用
|
黃品淯;黃于軒;溫淳如;林玉婷;林雨潔 |
| 朝陽科技大學 |
2022-03-08 |
我國銀行推動綠色金融政策之事件宣告效果
|
許育誠;劉香蓮;陳翰彰;廖柏誌;賴沂汭;邱子馨 |
| 朝陽科技大學 |
2022-03-08 |
會計師審計風險調控策略
|
林郁儒;潘昱宏;楊美綸;賴霈諭;涂瑋傑 |
| 淡江大學 |
2022-03-08 |
Measuring the cosmological density field twice: A novel test of dark energy using the CMB quadrupole
|
Liu, Guo-chin |
| 淡江大學 |
2022-03-08 |
111年臺灣學術資源影響力分析報告
|
王豐瑋;王宏德;吳柏岳;梁鴻栩 |
| 國立成功大學 |
2022-03-08 |
病理切片影像的脂滴分割方法與電腦程式產品
|
詹寶珠;CHUNG, PAU-CHOO;蔡弘文;TSAI, HUNG-WEN;吳俊忻;WU, JYUN-SIN;林于暄;LIN, YU-HSUAN;鄭國順;CHENG, KUO-SHENG |
| 國家衛生研究院 |
2022-03-08 |
Compositions and methods for enhancement of immune responses
|
Chen, HW;Leng, CH;Liu, SJ |
| 國家衛生研究院 |
2022-03-08 |
Opioid receptor modulators and use thereof
|
Ueng, SH;Yeh, SH;Loh, H;Chao, YS |
| 臺大學術典藏 |
2022-03-08T01:40:10Z |
導讀：於歷史書寫中思索命運的無常
|
洪瑟君; 洪瑟君; SE-CHUN HUNG |
| 臺大學術典藏 |
2022-03-08T01:52:29Z |
Evidence for human-environment interactions as the driver for the abandonment of long-term Neolithic occupation at the Wansan site(NE Taiwan) around the 7th century BCE
|
CHIANG, Chih-Hua |
| 臺大學術典藏 |
2022-03-08T03:43:58Z |
Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy
|
Chen Y.-L.; Tsai C.-L.; Cheng J.C.-H.; Wang C.-W.; SHIH-HUNG YANG; Tien Y.-W.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-08T03:43:59Z |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-�eB-related signaling
|
Kuo S.-H.; SHIH-HUNG YANG; Wei M.-F.; Lee H.-W.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:43:59Z |
Preoperative 2-[18F]FDG PET-CT aids in the prognostic stratification for patients with primary ampullary carcinoma
|
Chuang P.-J.; Wang H.-P.; Lin Y.-J.; Chen C.-C.; Tien Y.-W.; Hsieh M.-S.; SHIH-HUNG YANG; Yen R.-F.; Ko C.-L.; Wu Y.-W.; Cheng M.-F. |
| 臺大學術典藏 |
2022-03-08T03:44:00Z |
Metabolic alterations in pancreatic cancer detected by in vivo1h-mr spectroscopy: Correlation with normal pancreas, pet metabolic activity, clinical stages, and survival outcome
|
Chang C.-K.; Shih T.T.-F.; Tien Y.-W.; Chang M.-C.; Chang Y.-T.; SHIH-HUNG YANG; Cheng M.-F.; Chen B.-B. |
| 臺大學術典藏 |
2022-03-08T03:44:00Z |
C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin �\v
|
Kuo T.-C.; Wu M.-H.; SHIH-HUNG YANG; Chen S.-T.; Hsu T.-W.; Jhuang J.-Y.; Liao Y.-Y.; Tien Y.-W.; Huang M.-C. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study
|
Su Y.-Y.; Chiu Y.-F.; Li C.-P.; SHIH-HUNG YANG; Lin J.; Lin S.-J.; Chang P.-Y.; Chiang N.-J.; Shan Y.-S.; Ch��ang H.-J.; Chen L.-T. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients�� experience within a population-based study
|
Chiu T.-J.; Su Y.-Y.; SHIH-HUNG YANG; Li C.-P.; Bai L.-Y.; Chiang N.-J.; Chuang S.-C.; Shan Y.-S.; Chan D.-C.; Chen L.-T.; Yen C.-J.; Peng C.-M.; Chen Y.-Y.; Chen J.-S.; Chou W.-C. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
SHIH-HUNG YANG; Lu L.-C.; Kao H.-F.; Chen B.-B.; Kuo T.-C.; Kuo S.-H.; Tien Y.-W.; Bai L.-Y.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T. |
| 臺大學術典藏 |
2022-03-08T03:44:02Z |
S-1�Vassociated hypertriglyceridemia in a patient with pancreatic adenocarcinoma
|
Chen H.-W.; Kuo H.-Y.; Chen B.-B.; Tien Y.-W.; Kuo S.-H.; SHIH-HUNG YANG |
| 臺大學術典藏 |
2022-03-08T03:44:02Z |
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma�VTCOG T1211 study
|
Chiang N.-J.; Tsai K.K.; Hsiao C.-F.; SHIH-HUNG YANG; Hsiao H.-H.; Shen W.-C.; Hsu C.; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T. |
| 臺大學術典藏 |
2022-03-08T03:44:02Z |
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients
|
SHIH-HUNG YANG; Guo J.-C.; Hsu C.; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:03Z |
Postoperative imaging and tumor marker surveillance in resected pancreatic cancer
|
Wu H.; Guo J.-C.; SHIH-HUNG YANG; Tien Y.-W.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:03Z |
A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinoma
|
SHIH-HUNG YANG; Shao Y.-Y.; Lin C.-C.; Kuo S.-H.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:03Z |
Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer
|
Chen B.-B.; Tien Y.-W.; Chang M.-C.; Cheng M.-F.; Chang Y.-T.; SHIH-HUNG YANG; Wu C.-H.; Kuo T.-C.; Shih I.-L.; Yen R.-F.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-03-08T03:44:04Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
SHIH-HUNG YANG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:04Z |
Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan
|
Chang M.-C.; Wu C.-H.; SHIH-HUNG YANG; Liang P.-C.; Chen B.-B.; Jan I.-S.; Chang Y.-T.; Jeng Y.-M. |
| 臺大學術典藏 |
2022-03-08T03:44:04Z |
Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer
|
SHIH-HUNG YANG; Guo J.-C.; Yeh K.-H.; Tien Y.-W.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:05Z |
PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis
|
Chen B.-B.; Tien Y.-W.; Chang M.-C.; Cheng M.-F.; Chang Y.-T.; Wu C.-H.; Chen X.-J.; Kuo T.-C.; SHIH-HUNG YANG; Shih I.-L.; Lai H.-S.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-03-08T03:44:05Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
SHIH-HUNG YANG; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:05Z |
Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma
|
Chang M.-C.; Chang Y.-T.; Chen J.-Y.; Jeng Y.-M.; Yang C.-Y.; Tien Y.-W.; SHIH-HUNG YANG; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:06Z |
Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: A retrospective study
|
Guo J.-C.; SHIH-HUNG YANG |
| 臺大學術典藏 |
2022-03-08T03:44:06Z |
Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-�eb is associated with a poor prognosis of pancreatic cancer
|
SHIH-HUNG YANG; Hsu C.-H.; Lee J.-C.; Tien Y.-W.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-08T03:44:06Z |
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy
|
Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG; Huang S.-M.; Hsu C.; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-08T03:44:07Z |
Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma
|
SHIH-HUNG YANG; Lin L.-W.; Fang Y.-J.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:07Z |
A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor
|
SHIH-HUNG YANG; Lin C.-C.; Lin Z.-Z.; Tseng Y.-L.; Hong R.-L. |
| 臺大學術典藏 |
2022-03-08T03:44:07Z |
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials
|
SHIH-HUNG YANG; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-08T03:44:08Z |
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma
|
SHIH-HUNG YANG; Lin Z.-Z.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-08T03:44:08Z |
Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma [2]
|
SHIH-HUNG YANG; Kuo S.-H. |
